ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,312.80
      0.08%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      73.525
      -0.28%
      Bitcoin
      62,980.24
      -0.55%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. OncoCyte Corporation (OCX)

      7. OncoCyte Corporation (OCX) News

      OCX

      OncoCyte (OCX)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OCX
      DateTimeSourceHeadlineSymbolCompany
      08/20/20249:00AMGlobeNewswire Inc.PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics TechnologyNASDAQ:OCXOncocyte Corporation
      08/12/20244:10PMGlobeNewswire Inc.Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series StudyNASDAQ:OCXOncocyte Corporation
      08/09/20246:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      08/09/20246:25AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OCXOncocyte Corporation
      08/09/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
      08/08/20244:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
      08/08/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      08/08/20244:05PMGlobeNewswire Inc.Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 ResultsNASDAQ:OCXOncocyte Corporation
      08/05/20244:05PMGlobeNewswire Inc.Oncocyte Announces August Investor Conferences ParticipationNASDAQ:OCXOncocyte Corporation
      08/01/20244:05PMGlobeNewswire Inc.Oncocyte to Announce Second Quarter 2024 Financial Results on August 8NASDAQ:OCXOncocyte Corporation
      07/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      07/11/20248:00AMGlobeNewswire Inc.MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" EpisodeNASDAQ:OCXOncocyte Corporation
      06/24/202412:41PMGlobeNewswire Inc.Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership MoveNASDAQ:OCXOncocyte Corporation
      06/17/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      06/17/20244:05PMGlobeNewswire Inc.Oncocyte Appoints Andrea James as Chief Financial OfficerNASDAQ:OCXOncocyte Corporation
      06/04/20245:02PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
      06/03/20242:13PMGlobeNewswire Inc.Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft StudyNASDAQ:OCXOncocyte Corporation
      05/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      05/30/20244:47PMGlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
      05/23/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      05/23/202411:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
      05/23/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
      05/22/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
      05/22/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
      05/17/20245:11PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
      05/15/20244:05PMGlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
      05/13/20248:00AMGlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
      05/10/20245:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
      05/07/20249:19AMGlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
      04/12/20246:00AMGlobeNewswire Inc.Oncocyte Reports Full Year 2023 Financial ResultsNASDAQ:OCXOncocyte Corporation
       Showing the most relevant articles for your search:NASDAQ:OCX